| Particulars | Mar2024 | Mar2023 | Mar2022 | Mar2021 |
|---|---|---|---|---|
| Revenue From Operations | 1,537.59 | 1,338.88 | 1,449.27 | 1,112.42 |
| Sale of Products | 1,529.43 | 1,335.48 | 1,446.05 | 1,101.72 |
| Sale of Services | 0.00 | 0.00 | 0.00 | 0.00 |
| Income from Investment and Financial Services | 0.00 | 0.00 | 0.00 | 0.00 |
| Particulars | Mar2024 | Mar2023 | Mar2022 | Mar2021 |
|---|---|---|---|---|
| Fixed Assets | 307.35 | 266.97 | 251.80 | 224.52 |
| Property, Plant and Equipments | 213.20 | 167.00 | 146.65 | 129.29 |
| Right-of-Use Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| Intangible Assets | 94.14 | 99.97 | 105.15 | 95.24 |
| Market Cap (Rs in Crs) | 2,636.75 | |
|---|---|---|
| P/E | 20.3 | |
| Book Value (Rs) | 20.95 | |
| Div (%) | 0 | |
| Market Lot | 1 | |
| EPS (TTM) | 2.37 | |
|---|---|---|
| Price/Book | 2.30 | |
| Div Yield.(%) | 0 | |
| Face value (RS) | 2 | |
| Deliverables (%) | 45.46 | |
| Company Name | Market Cap (₹) | LTP (₹) | Prev. Close (₹) | Chg(%) |
52 Week H/L(₹)
|
|---|---|---|---|---|---|
| Sun Pharmaceuti... | 3,96,394.13 | 1,652.10 | 1,688.75 | -2.17 | 1,960.20 - 1,376.75 |
| Divis Laborator... | 1,42,920.32 | 5,383.70 | 5,389.50 | -0.11 | 6,448.75 - 3,640.10 |
| Cipla Ltd | 1,14,382.81 | 1,416.30 | 1,433.45 | -1.20 | 1,702.00 - 1,310.05 |
| Torrent Pharmac... | 1,05,811.91 | 3,126.55 | 3,244.50 | -3.64 | 3,589.95 - 2,508.65 |
| Mankind Pharma ... | 95,480.99 | 2,314.25 | 2,343.55 | -1.25 | 3,050.00 - 1,910.10 |
Total Foreign
Total Institutions
Total Govt Holding
Total Non Promoter Corporate Holding
Total Promoters
Total Public & others
| Category | No. of Shares | Percentage |
|---|---|---|
| Total Foreign | 5,82,21,189 | 10.63 |
| Total Institutions | 89,98,550 | 1.64 |
| Total Govt Holding | 60,000 | 0.01 |
| Total Non Promoter Corporate Holding | 1,90,62,653 | 3.48 |
| Total Promoters | 19,53,71,588 | 35.66 |
| Total Public & others | 266239719 | 48.59 |
| Total | 54,79,53,699 | 100 |
